Abingworth closes 11th life sciences fund at $105 mln
Abingworth has raised $105 million for its oversubscribed 11th life sciences fund. The target was $100 million. Abingworth Clinical Co-Development Fund's lead investor is the European Investment Fund.
21 January 2016•2 mins read
